… In this Review, we discuss the emerging non-dopaminergic therapies for PD with a focus
on disease modification and treatment of motor symptoms. We examine pharmacological …

… disease modifying treatments for PD, with management options consisting mainly of dopaminergic
drugs… In this review, we discuss the emerging treatment approaches, and the form that …

… of the motor symptoms associated with Parkinson’s disease (PD). Even … drugs are being
developed to optimize the treatment response.[Citation2] Here we review new and emerging …

Parkinson’s disease (PD) is a common neurodegenerative disease typified by a movement
disorder consisting of bradykinesia, rest tremor, rigidity, and postural instability. Treatment …

ParkinsonLs disease (PD) is one of the most common neurodegenerative diseases. Genetic
factors are involved in< 10% of PD cases, while the majority of PD cases have no …

… developing alongside the advancement of emerging technologies such as genomics and …
drugs to treat PD. In summary, numerous possibilities exist in the field of target-based drug …

… (DAergic) drugs have been considered as the main therapy against motor symptoms of
Parkinson's disease (PD… Classical drug treatments with the emerging new formulations and novel …

Parkinson’s disease (PD) is a neurodegenerative disorder pathologically distinguished by
degeneration of dopaminergic neurons in the substantia nigra pars compacta. Muscle rigidity, …

… drugs entered clinical trials, the development of new drugs shows promising prospects. In
this review, we discuss the emerging … drugs, highlighting the development of new drugs that …

… New drugs have failed in clinical trials … one drug work for all Parkinson's disease patients,
when we know this premise is wrong because (1) Parkinson's disease is not a single disease, …